Overview
Publication Venue For
Highlights From the 2019 HIV Diagnostics Conference: Optimizing Testing for HIV, STIs, and HCV..
47:S2-S7.
2020
Performance of 4 Molecular Assays for Detection of Chlamydia and Gonorrhea in a Sample of Human Immunodeficiency Virus-Positive Men Who Have Sex With Men..
47:158-161.
2020
Performance of 4 Molecular Assays for Detection of Chlamydia and Gonorrhea in a Sample of Human Immunodeficiency Virus-Positive Men Who Have Sex with Men.
47:158-161.
2020
Identifying Missed Opportunities for Human Immunodeficiency Virus Pre-exposure Prophylaxis during Preventive Care and Reproductive Visits in Adolescents in the Deep South.
47:88-95.
2020
Patients Are Willing to Wait for Rapid Sexually Transmitted Infection Results in a University Student Health Clinic.
47:67-69.
2020
Patients Are Willing to Wait for Rapid Sexually Transmitted Infection Results in a University Student Health Clinic..
47:67-69.
2020
Sexually Transmitted Infections in Pregnancy and Reproductive Health: Proceedings of the STAR Sexually Transmitted Infection Clinical Trial Group Programmatic Meeting.
47:5-11.
2020
Pharmacokinetic and Pharmacodynamic Effects of Metronidazole May Account for the Superior Efficacy of Multidose Therapy among Women with Trichomoniasis.
46:751-752.
2019
Mycoplasma genitalium Coinfection in Women With Chlamydia trachomatis Infection.
46:E101-E104.
2019
The National Network of Sexually Transmitted Disease Clinical Prevention Training Centers Turns 40-A Look Back, a Look Ahead.
46:487-492.
2019
Recent Developments in Biomedical Issues in Sexually Transmitted Infections: Implications for Behavioral Parameters of Interest.
46:E65-E67.
2019
Delay in Seeking Health Care Services After Onset of Urethritis Symptoms in Men..
46:317-320.
2019
Delay in Seeking Health Care Services after Onset of Urethritis Symptoms in Men.
46:317-320.
2019
Efficacy and Safety of Single-Dose Oral Delafloxacin Compared with Intramuscular Ceftriaxone for Uncomplicated Gonorrhea Treatment: An Open-Label, Noninferiority, Phase 3, Multicenter, Randomized Study.
46:279-286.
2019
Is It Time to Stop Using Single-dose Oral Metronidazole for the Treatment of Trichomoniasis in Women?.
46:E57-E59.
2019
Optimal Timing for Trichomonas vaginalis Test of Cure Using Nucleic Acid Amplification Testing.
46:312-316.
2019
Mycoplasma genitalium infections with macrolide and fluoroquinolone resistance-Associated mutations in heterosexual african American couples in Alabama.
46:18-24.
2019
Sexually Transmitted Infection Prevalence in Women with HIV: Is There a Role for Targeted Screening?.
45:762-769.
2018
Mycoplasma genitalium Infection in Kenyan and US Women.
45:514-521.
2018
Defining the Urethritis Syndrome in Men Using Patient Reported Symptoms.
45:e40-e42.
2018
Health Care Provider Perceptions of a Sexually Transmitted Infection Self-testing Program in an HIV Care Clinic.
45:417-421.
2018
Is There a Continuum of Risk for Sexually Transmitted Infections among African American Women?.
45:e20-e22.
2018
Screening for Trichomonas vaginalis in a Large High-Risk Population: Prevalence among Men and Women Determined by Nucleic Acid Amplification Testing.
45:e23-e24.
2018
An exploration of factors impacting preexposure prophylaxis eligibility and access among syringe exchange users.
45:217-221.
2018
The Need to Promote Sexual Health in America: A New Vision for Public Health Action.
44:579-585.
2017
Risk Factors for Incidence of Sexually Transmitted Infections among Women in a Human Immunodeficiency Virus Chemoprevention Trial: VOICE (MTN-003).
44:135-140.
2017
Sexually Transmitted Infections and Human Immunodeficiency Virus: Are We Applying the Lessons Learned?.
44:141-142.
2017
Impact of eligibility criteria on participant enrollment for a randomized clinical trial of gonorrhea treatment.
44:362-364.
2017
Rate of Decline in Nontreponemal Antibody Titers and Seroreversion after Treatment of Early Syphilis.
44:7-11.
2017
Trichomonas vaginalis treated with boric acid in a metronidazole allergic female.
44:120.
2017
Utilization of the Cepheid Xpert® CT/NG Sample Adequacy Control to Determine the Influence of the Urethral Swab on Cellular Content in Post-Swab versus Pre-Swab Urine.
44:68-69.
2017
Genotype-specific concordance of chlamydia trachomatis genital infection within heterosexual partnerships.
43:741-749.
2016
Reducing Missed Opportunities: Pairing Sexually Transmitted Infection Screening with Syringe Exchange Services.
43:706-708.
2016
Azithromycin treatment failure for chlamydia trachomatis among heterosexual men with nongonococcal urethritis.
43:599-602.
2016
Ocular Syphilis in Context.
43:528-529.
2016
Trichomonas vaginalis Nucleic Acid Amplification Testing at an Urban HIV Clinic.
43:483-488.
2016
Variations in Clinical Presentation of Ocular Syphilis: Case Series Reported from a Growing Epidemic in the United States.
43:519-523.
2016
Rapid Diagnosis of Trichomonas vaginalis by Testing Vaginal Swabs in an Isothermal Helicase-Dependent AmpliVue Assay.
43:369-373.
2016
Willingness to Disclose Sexually Transmitted Infection Status to Sex Partners Among College-Aged Men in the United States..
43:204-206.
2016
Barriers to bacterial sexually transmitted infection testing of HIV-infected men who have sex with men engaged in HIV primary care.
42:590-594.
2015
Comparison of Antimicrobial Susceptibility of Urogenital Neisseria gonorrhoeae Isolates Obtained from Women and Men.
42:434-439.
2015
A phase 3, multicenter, randomized, double-blind, vehicle-controlled study evaluating the safety and efficacy of metronidazole vaginal gel 1.3% in the treatment of bacterial vaginosis.
42:376-381.
2015
Intimate partner violence and correlates with risk behaviors and HIV/STI diagnoses among men who have sex with men and men who have sex with men and women in China: A hidden epidemic.
42:387-392.
2015
Generalized Testing for Gonococcal Antibiotic Susceptibility or Sentinel Surveillance.
42:417-418.
2015
Management of Pelvic Inflammatory Disease in Selected US Sexually Transmitted Disease Clinics: Sexually Transmitted Disease Surveillance Network, January 2010-December 2011.
42:429-433.
2015
Performance of the BD CTQx and GCQx amplified assays on the BD Viper LT compared with the BD viper XTR system.
42:521-523.
2015
Relationship of specific bacteria in the cervical and vaginal microbiotas with cervicitis.
42:475-481.
2015
Duration of polymerase Chain reaction-detectable DNA after treatment of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis Infections in Women.
41:215-219.
2014
Azithromycin for rectal chlamydia: Is it time to leave azithromycin on the shelf?..Not yet.
41:86-88.
2014
Preferred methods of sexually transmitted infection service delivery among an urban sample of underserved midwestern men.
41:129-132.
2014
Sexual partnership characteristics of African American women who have sex with women; impact on sexually transmitted infection risk.
41:611-617.
2014
Suspected heterosexual transmission of bacterial vaginosis without seminal fluid exposure.
41:58-60.
2014
Bacterial vaginosis-associated bacteria in men: Association of Leptotrichia/Sneathia spp. with nongonococcal urethritis.
40:944-949.
2013
Sexual history taking and sexually transmitted infection screening in patients initiating erectile dysfunction medication therapy.
40:836-838.
2013
Trichomonas vaginalis in selected US sexually transmitted disease clinics: Testing, screening, and prevalence.
40:865-869.
2013
Bacterial vaginosis among African American women who have sex with women.
40:751-755.
2013
Incident anal human papillomavirus and human papillomavirus-related sequelae in HIV-infected versus HIV-uninfected adolescents in the United States.
40:715-720.
2013
Intravaginal metronidazole/miconazole for the treatment of vaginal trichomoniasis.
40:710-714.
2013
A prospective cohort study comparing the effect of single-dose 2 G metronidazole on trichomonas vaginalis infection in HIV-seropositive versus HIV-seronegative women.
40:499-505.
2013
Is there evidence of the new variant chlamydia trachomatis in the United States?.
40:352-353.
2013
Prevalence and treatment outcome of cervicitis of unknown etiology.
40:379-385.
2013
Sexual behaviors, perception of sexually transmitted infection risk, and practice of safe sex among southern african american women who have sex with women.
40:395-400.
2013
American sexually transmitted diseases association and the thomas parran award: Past, present, and future.
40:275-276.
2013
Chlamydia trachomatis infection among women 26 to 39 years of age in the united states, 1999 to 2010.
40:335-337.
2013
Remembering thomas parran, his contributions and missteps going forward: History informs us.
40:281-282.
2013
Vaginal swabs are the optimal specimen for detection of genital chlamydia trachomatis or neisseria gonorrhoeae using the cobas 4800 CT/NG test.
40:247-250.
2013
Predictors of undiagnosed herpes simplex virus type 2 seropositivity among persons attending an HIV care clinic.
39:857-859.
2012
Prevalence of the 23S rRNA A2058G point mutation and molecular subtypes in treponema pallidum in the United States, 2007 to 2009.
39:794-798.
2012
Rapid plasma reagin titer variation in the 2 weeks after syphilis therapy.
39:645-647.
2012
The posttrial effect of oral periodic presumptive treatment for vaginal infections on the incidence of bacterial vaginosis and lactobacillus colonization.
39:361-365.
2012
Incidence, prevalence, and epidemiology of herpes simplex virus-2 in HIV-1-positive and HIV-1-negative adolescents.
39:300-305.
2012
Clinical evaluation of the BD ProbeTec ™ Neisseria gonorrhoeae Q x Amplified DNA Assay on the BD Viper ™ System with XTR™ Technology.
39:147-153.
2012
Prevalence and risk factors associated with herpes simplex virus-2 infection in a contemporary cohort of HIV-infected persons in the united states.
39:154-160.
2012
Evaluation of the Roche cobas® CT/NG test for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in male urine..
39:543-549.
2012
Genotypic characterization of Trichomonas vaginalis isolates among women who have sex with women in sexual partnerships..
39:556-558.
2012
HPV vaccine implementation in STD clinics-STD surveillance network.
39:32-34.
2012
Ongoing sexually transmitted disease acquisition and risk-taking behavior among US HIV-infected patients in primary care: Implications for prevention interventions.
39:1-7.
2012
Effect of sexual activity on vaginal colonization with hydrogen peroxide-producing lactobacilli and gardnerella vaginalis.
38:1137-1144.
2011
Sexually transmitted infections and risk behaviors among African American women who have sex with women: Does sex with men make a difference?.
38:1118-1125.
2011
Antimicrobial resistant gonorrhea in Atlanta: 1988-2006.
38:780-782.
2011
The natural history of incident gonococcal infection in adolescent women.
38:750-754.
2011
Assessing male condom failure and incorrect use.
38:580-586.
2011
Clinical evaluation of the BD probetec™ chlamydia trachomatis Qx amplified DNA assay on the BD viper™ system with XTR™ technology.
38:603-609.
2011
Prevalence of bacterial vaginosis and vulvovaginal candidiasis mixed infection in a southeastern American STD clinic.
38:672-674.
2011
Changing sexually transmitted infection screening protocol will result in improved case finding for trichomonas vaginalis among high-risk female populations.
38:398-400.
2011
Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (The SUN Study).
38:253-259.
2011
Characteristics of women reporting multiple recent sex partners presenting to a sexually transmitted disease clinic for care.
38:210-215.
2011
STD/HIV risk among adults in the primary care setting: Are we adequately addressing our patients'needs?.
38:30-32.
2011
Bacterial vaginosis: Identifying research gaps proceedings of a workshop sponsored by DHHS/NIH/NIAID.
37:732-744.
2010
Epidemiological synergy of trichomonas vaginalis and HIV in Zimbabwean and South African women.
37:460-466.
2010
Even NHANES evolves: Some surprising findings about women who have sex with women.
37:414-415.
2010
A randomized controlled trial of partner notification methods for prevention of trichomoniasis in women.
37:392-396.
2010
Prevalence and risks for bacterial vaginosis in women who have sex with women.
37:335-339.
2010
Spontaneous resolution of extragenital chlamydial and gonococcal infections prior to therapy.
37:343-344.
2010
Walter E. Stamm, MD, 1945-2009.
37:281-282.
2010
Herpes simplex virus in African American heterosexual males: The roles of age and male circumcision.
37:217-222.
2010
Race of male sex partners and occurrence of bacterial vaginosis.
37:184-190.
2010
Personal hygienic behaviors and bacterial vaginosis.
37:94-99.
2010
Concordance of rectal and cervical chlamydia trachomatis OmpA genotypes infecting women in Birmingham, Alabama.
37:32-33.
2010
Evaluation of azithromycin resistance in Treponema pallidum specimens from madagascar.
36:775-776.
2009
Implementation of routine access to herpes simplex virus type 2 antibody testing in a public health sexually transmitted disease clinic.
36:724-728.
2009
Disentangling contributions of reproductive tract infections to hiv acquisition in african women.
36:357-364.
2009
The association between oral contraceptives, depot-medroxyprogesterone acetate, and trichomoniasis.
36:336-340.
2009
A 15-Minute interactive, computerized condom use intervention with biological endpoints.
36:73-78.
2009
Prevalence of gardnerella vaginalis in male sexual partners of women with and without bacterial vaginosis.
36:92-94.
2009
Absence of lymphogranuloma venereum strains among rectal Chlamydia trachomatis outer membrane protein a genotypes infecting women and men who have sex with men in Birmingham, Alabama.
35:856-858.
2008
Sexual risk behaviors and sexually transmitted infection prevalence in an outpatient psychiatry clinic.
35:877-882.
2008
Chlamydia positivity in american Indian/Alaska native women screened in family planning clinics, 1997-2004.
35:753-757.
2008
Immunogenetic correlates of neisseria gonorrhoeae infection in adolescents.
35:656-661.
2008
Risk factors for incident herpes simplex type 2 virus infection among women attending a sexually transmitted disease clinic.
35:679-685.
2008
Association of mobiluncus curtisii with recurrence of bacterial vaginosis.
35:611-613.
2008
Chlamydia prevalence among college students: Reproductive and public health implications.
35:529-532.
2008
Chlamydia antibodies, chlamydia heat shock protein, and adverse sequelae after pelvic inflammatory disease: The PID Evaluation and Clinical Health (PEACH) Study.
35:129-135.
2008
The natural history of untreated Chlamydia trachomatis infection in the interval between screening and returning for treatment.
35:119-123.
2008
Acceptability of urine-based screening for Chlamydia trachomatis in asymptomatic young men: a systematic review..
35.
2008
Chlamydia trachomatis positivity rates among men tested in selected venues in the United States: a review of the recent literature..
35.
2008
Neonatal herpes - The forgotten perinatal infection.
35:22-24.
2008
The cost-effectiveness of screening men for Chlamydia trachomatis: a review of the literature..
35.
2008
The program cost and cost-effectiveness of screening men for Chlamydia to prevent pelvic inflammatory disease in women..
35.
2008
Longitudinal association between hormonal contraceptives and bacterial vaginosis in women of reproductive age.
34:954-959.
2007
Natural history of asymptomatic bacterial vaginosis in a high-risk group of women.
34:876-877.
2007
Population-based outreach for chlamydia screening in men: Results from a randomized trial.
34:837-839.
2007
Within the hidden epidemic: Sexually transmitted diseases and HIV/AIDS among American Indians and Alaska natives.
34:767-777.
2007
Incidence of neonatal herpes simplex virus infections in a managed-care population.
34:704-708.
2007
Self-reported mechanical problems during condom use and semen exposure: Comparison of two randomized trials in the United States of America and Brazil.
34:557-562.
2007
Pelvic examination findings and chlamydia trachomatis infection in asymptomatic young women screened with a nucleic acid amplification test.
34:335-338.
2007
Acceptability of urine-based screening for Chlamydia trachomatis to asymptomatic young men and their providers.
34:147-153.
2007
Superficial hepatic capsular lesions in a systemically ill young woman.
34:139-140.
2007
Sexually transmitted infections and risk factors among truck stand workers in Dhaka, Bangladesh.
34:99-103.
2007
Sexually transmitted infections among urban shelter clients.
33:666-669.
2006
A pilot study of vaginal flora changes with randomization to cessation of douching.
33:610-613.
2006
Association of Chlamydia trachomatis serovar Ia infection with black race in a sexually transmitted diseases clinic patient population in Birmingham, Alabama.
33:621-624.
2006
Health insurance coverage, health care-seeking behaviors, and genital chlamydial infection prevalence in sexually active young adults.
33:389-396.
2006
The impact of natural history parameters on the cost-effectiveness of Chlamydia trachomatis screening strategies.
33:428-436.
2006
Prevalence of Neisseria gonorrhoeae among men screened for Chlamydia trachomatis in four United States Cities, 1999-2003.
33:314-319.
2006
Vaginal douche practices among black women at risk: Exploring douching prevalence, reasons for douching, and sexually transmitted disease infection.
33:215-219.
2006
Chlamydial infections among female adolescents screened in juvenile detention centers in Washington State, 1998-2002.
33:63-67.
2006
An intervention to reduce vaginal douching among adolescent and young adult women: A randomized, controlled trial.
32:752-758.
2005
Vaginal swabs are the specimens of choice when screening for Chlamydia trachomatis and Neisseria gonorrhoeae: Results from a multicenter evaluation of the APTIMA assays for both infections.
32:725-728.
2005
Women find it easy and prefer to collect their own vaginal swabs to diagnose Chlamydia trachomatis or Neisseria gonorrhoeae infections.
32:729-733.
2005
A randomized trial of clinician-delivered interventions promoting barrier contraception for sexually transmitted disease prevention.
32:672-679.
2005
Risk factors for bacterial vaginosis in women at high risk for sexually transmitted diseases.
32:654-658.
2005
Chlamydial and gonococcal infection in men without polymorphonuclear leukocytes on gram stain: Implications for diagnostic approach and management.
32:630-634.
2005
Dangerous assumptions: Lesbians and sexual death.
32:570-571.
2005
Neonatal herpes should be a reportable disease.
32:521-525.
2005
Bacterial vaginosis (BV) and the risk of incident gonococcal or chlamydial genital infection in a predominantly black population.
32:413-417.
2005
The cost effectiveness of gonorrhea screening in urban emergency departments.
32:425-436.
2005
Chlamydia screening of at-risk young women in managed health care: Characteristics of top-performing primary care offices.
32:382-386.
2005
Prevalence of Chlamydia trachomatis infection among men screened in 4 U.S. cities.
32:74-77.
2005
Female condom and male condom failure among women at high risk of sexually transmitted diseases.
32:35-43.
2005
Sexually transmitted disease/HIV transmission risk behaviors and sexually transmitted disease prevalence among HIV-positive men receiving continuing care.
32:20-26.
2005
Predictors of bacterial vaginosis in adolescent women who douche.
31:433-436.
2004
Vaginal lactobacilli in adolescents: Presence and relationship to local and systemic immunity, and to bacterial vaginosis.
31:393-400.
2004
Re-evaluating Selective Screening Criteria for Chlamydial Infection among Women in the U.S. Pacific Northwest.
31:283-289.
2004
The Effect of Urine Testing in Evaluations of the Sensitivity of the Gen-Probe APTIMA® Combo 2 Assay on Endocervical Swabs for Chlamydia trachomatis and Neisseria gonorrhoeae: The Infected Patient Standard Reduces Sensitivity of Single Site Evaluation.
31:273-277.
2004
A Randomized, Double-Blind Clinical Trial of Vaginal Acidification versus Placebo for the Treatment of Symptomatic Bacterial Vaginosis.
31:236-238.
2004
Risk-Taking and Health-Seeking Behavior in Men with a History of Urethritis: Is There a Learning Curve?.
31:225-228.
2004
Prevalence and Risk Factors for Infection with Herpes Simplex Virus Type-1 and -2 among Lesbians.
30:890-895.
2003
Acceptability of Urine Screening for Neisseria gonorrheae and Chlamydia trachomatis in Adolescents at an Urban Emergency Department.
30:850-853.
2003
Early onset of vaginal douching is associated with false beliefs and high-risk behavior.
30:689-693.
2003
Comparison of STD burden and risk among men with and without regular doctors attending a southern urban STD clinic.
30:512-515.
2003
A refined estimate of the average lifetime cost of pelvic inflammatory disease.
30:369-378.
2003
Prevalence and factors associated with gonorrhea and chlamydial infection in at-risk females presenting to an urban emergency department.
30:335-339.
2003
The clinical and economic consequences of screening young men for genital chlamydial infection.
30:99-106.
2003
The relationship of serovar to clinical manifestations of urogenital Chlamydia trachomatis infection.
30:160-165.
2003
Demonstration of declining community prevalence of Chlamydia trachomatis infection using sentinel surveillance.
30:20-24.
2003
Why women douche and why they may or may not stop.
30:71-74.
2003
Findings from STD screening of adolescents and adults entering corrections facilities: Implications for STD control strategies.
29:834-839.
2002
Projection of the future dimensions and costs of the genital herpes simplex type 2 epidemic in the United States.
29:608-622.
2002
Association of adolescents' history of sexually transmitted disease (STD) and their current high-risk behavior and STD status: A case for intensifying clinic-based prevention efforts.
29:503-509.
2002
Sexual behavior of international travelers visiting Peru.
29:510-513.
2002
A randomized, comparative pilot study of azithromycin versus benzathine penicillin G for treatment of early syphilis.
29:486-490.
2002
Associations between biologically confirmed marijuana use and laboratory-confirmed sexually transmitted diseases among African American adolescent females.
29:387-390.
2002
Epidemiology of anorectal chlamydial and gonococcal infections among men having sex with men in Seattle: Utilizing serovar and auxotype strain typing.
29:189-195.
2002
Interrelationships of bacterial vaginosis and cervical inflammation.
29:59-64.
2002
Screening women in jails for chlamydial and gonococcal infection using urine tests feasibility, acceptability, prevalence, and treatment rates.
29:271-276.
2002
Sexual risk behaviors associated with having older sex partners: A study of black adolescent females.
29:20-24.
2002
Erratum: The relative increase in prevalence using LCR was highest among men with < 5 polymorphonuclear leukocytes per high-power (1000×) field (PMN/HPF) on urethral Gram stain regardless of symptoms, and in symptomatic men with gonorrhea diagnosed by urethral culture (Sexually Transmitted Diseases 28:4 (220)).
28:429.
2001
Socioeconomic status and self-reported gonorrhea among African American female adolescents.
28:236-239.
2001
Condom carrying is not associated with condom use and lower prevalence of sexually transmitted diseases among minority adolescent females.
28:444-447.
2001
Modification of syphilitic genital ulcer manifestations by coexistent HIV infection.
28:448-454.
2001
Motorcycle taxi drivers and sexually transmitted infections in a Peruvian Amazon city.
28:11-13.
2001
Prevalence of Mobiluncus spp among women with and without bacterial vaginosis as detected by polymerase chain reaction.
28:195-199.
2001
Psychosocial correlates of adolescents' worry about STD versus HIV infection: Similarities and differences.
28:208-213.
2001
Single-dose gatifloxacin compared with ofloxacin for the treatment of uncomplicated gonorrhea: A randomized, double-blind, multicenter trial.
28:136-142.
2001
Urine-based screening for Chlamydia trachomatis in men attending sexually transmitted disease clinics.
28:219-225.
2001
Validity of self-reported sexually transmitted diseases among african american female adolescents participating in an HIV/STD prevention intervention trial.
28:468-471.
2001
High prevalence of asymptomatic STDs in incarcerated minority male youth: A case for screening.
27:175-177.
2000
Seroprevalence and risk factors of hepatitis B, hepatitis C, and human cytomegalovirus among HIV-infected and high-risk uninfected adolescents: Findings of the reach study.
27:296-303.
2000
Practice patterns for the elicitation of sexual history, education, and counseling among providers of STD services: Results from the gonorrhea community action project (GCAP).
26:584-589.
1999
Double-blind comparison of trovafloxacin and doxycycline in the treatment of uncomplicated chlamydial urethritis and cervicitis.
26:531-536.
1999
Patterns of Chlamydia trachomatis testing and follow-up at a University Hospital Medical Center.
26:496-499.
1999
Trichomonas vaginalis - No longer a minor STD.
26:388-389.
1999
Correlates of herpes simplex virus seroprevalence among women attending a sexually transmitted disease clinic.
26:329-334.
1999
Self-reported sexual activity and condom use among symptomatic clients attending STD clinics.
26:286-290.
1999
Prevalence of gonococcal and chlamydial infections in commercial sex workers in a Peruvian Amazon City.
26:103-107.
1999
Under the influence: Risky sexual behavior and substance abuse among driving under the influence offenders.
26:87-92.
1999
Determinants of reinfection with Chlamydia trachomatis.
26:4-11.
1999
Measured versus self-reported compliance with doxycycline therapy for chlamydia-associated syndromes: High therapeutic success rates despite poor compliance.
26:272-280.
1999
Mechanical failure of the latex condom in a cohort of women at high STD risk.
26:450-458.
1999
Prospective study of barrier contraception for the prevention of sexually transmitted diseases: Study design and general characteristics of the study group.
26:127-136.
1999
The rapid test paradox: When fewer cases detected lead to more cases treated: A decision analysis of tests for Chlamydia trachomatis.
26:232-240.
1999
Objective markers of condom failure.
25:427-432.
1998
Compliance with doxycycline therapy in sexually transmitted diseases clinics.
25:1-4.
1998
Patients attending STD clinics in an evolving health care environment: Demographics, insurance coverage, preferences for STD services, and STD morbidity.
24:599-605.
1997
Delayed presentation to clinics for sexually transmitted diseases by symptomatic patients: A potential contributor to continuing STD morbidity.
24:443-448.
1997
Definitions of genital ulcer disease and variation in risk for prevalent human immunodeficiency virus infection.
24:436-442.
1997
Self- treatment patterns among clients attending sexually transmitted disease clinics and the effect of self-treatment on STD symptom duration.
24:372-377.
1997
Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women: Implications for a national chlamydia control strategy.
24:131-141.
1997
Positive screening tests for gonorrhea and chlamydial infection fail to lead consistently to treatment of patients attending a sexually transmitted disease clinic.
24:181-184.
1997
Spontaneous clearance of chlamydia trachomatis infection in untreated patients.
24:229-235.
1997
The use of sequential self-obtained vaginal smears for detecting changes in the vaginal flora.
24:236-239.
1997
Biomedical issues in syphilis control.
23:5-8.
1996
Declining prevalence of chlamydial infection among adolescent girls.
23:226-229.
1996
Therapeutic efficacy and complications of excisional biopsy of condyloma acuminatum.
23:273-276.
1996
Tuberculosis screening in a sexually transmitted diseases clinic.
23:299-303.
1996
Condom use to prevent incident stds: The validity of self-reported condom use.
22:15-21.
1995
Laboratory to laboratory variation in chlamydia trachomatis culture practices.
22:322-326.
1995
Metronidazole: Utilization in the obstetric and gynecologic patient.
22:370-376.
1995
Development of sexually transmitted diseases treatment guidelines, 1993. New methods, recommendations, and research priorities. STD Treatment Guidelines Project Team and Consultants..
21:S96-101.
1994
Alcohol and other substance use in std clinic patients: Relationships with stds and prevalent hiv infection.
21:220-225.
1994
Characterization of patients accepting and refusing routine, voluntary hiv antibody testing in public sexually transmitted disease clinics.
21:31-35.
1994
Efficacy of 250 mg trospectomycin sulfate im vs. 250 mg ceftriaxone im for treatment of uncomplicated gonorrhea.
21:213-216.
1994
Routine serologic screening for syphilis in hospitalized patients: High prevalence of unsuspected infection in the elderly.
21:133-136.
1994
Multicenter, comparative study of cefotaxime and ceftriaxone for treatment of uncomplicated gonorrhea.
20:269-273.
1993
Disease prevalence among women attending a sexually transmitted disease clinic varies with reason for visit.
19:88-91.
1992
Gene typing of chlamydia trachomatis by polymerase chain reaction and restriction endonuclease digestion.
19:303-308.
1992
Nonculture tests for genital tract chlamydial infection: What does the package insert mean, and will it mean the same thing tomorrow?.
19:243-244.
1992
Prevalence and patterns of condom use among patients attending a sexually transmitted disease clinic.
19:175-180.
1992
Prevalence and patterns of condom use among patients attending a sexually transmitted disease clinic.
19:175-180.
1992
Temporal trends in gonococcal antibiotic resistance in baltimore.
19:213-218.
1992
Genital human papillomavirus infections in patients attending an inner-city STD clinic..
18:183-187.
1991
Surrogate methods to diagnose gonococcal and chlamydial cervicitis: Comparison of leukocyte esterase dipstick, endocervical gram stain, and culture.
18:211-216.
1991
Behavioral relapse among homosexually active men: Implications for std control.
17:161-162.
1990
Evaluation of abbott test pack® chlamydia for detection of chlamydia trachomatis in patients attending sexually transmitteddiseases clinics.
17:147-151.
1990
Reproductive health practices in women attending an inner-city std clinic.
17:133-137.
1990
Routine voluntary hiv screening in std clinic clients: Characterization of infected clients.
17:211-215.
1990
Routine voluntary hiv screening in std clinic clients: Characterization of infected clients.
17:211-215.
1990
Trends in sexually transmitted diseases in homosexually active men in king county, washington, 1980–1990.
17:211-215.
1990
Multicenter, comparative study of enoxacin and ceftriaxone for treatment of uncomplicated gonorrhea.
16:148-151.
1989
Auxotype/serovar diversity and antimicrobial resistance of neisseria gonorrhoeae in two mid-sized american cities.
14:141-146.
1987
Ceftriaxone for treatment of uncomplicated gonorrhea: Routine use of a single 125-mg dose in a sexually transmitted disease clinic.
14:227-230.
1987
Detection of treponema pallidum by a fluorescent monoclonal antibody test.
14:156-159.
1987
Epidemiology of gonorrhea: Distribution and temporal changes in auxotype/serovar classes of neisseria gonorrhoeae.
14:26-32.
1987
Analysis of dna from recurrent genital herpes simplex virus isolates by restriction endonuclease digestion.
13:61-66.
1986
Ceftriaxone therapy for asymptomatic neurosyphilis: Case report and western blot analysis of serum and cerebrospinal fluid IgG response to therapy.
13:185-188.
1986
Serogrouping of neisseria gonorrhoeae: Correlation of serogroup with disseminated gonococcal infection.
11:77-80.
1984
Isolation of Mycoplasma hominis and Ureaplasma urealyticum from amniotic fluid at 16-20 weeks of gestation: potential effect on outcome of pregnancy..
10:294-302.
1983
Isolation of mycoplasma hominis and ureaplasma urealyticum from amniotic fluid at 16-20 weeks of gestation: Potential effect on outcome of pregnancy.
10:294-302.
1983
